phosphorylcholine has been researched along with Cutaneous Mastocytosis in 1 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with miltefosine, but not with clobetasol, was often associated with eczematous skin irritation, which may, at least in part, be related to the formulation of miltefosine containing the potentially irritating alkanol propanediol as the vehicle." | 6.75 | Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial. ( Belloni, B; Brockow, K; Eben, R; Hartmann, B; Hartmann, K; Maurer, M; Ruëff, F; Schoepke, N; Siebenhaar, F; Staubach, P; Weber, A, 2010) |
| "Treatment with miltefosine, but not with clobetasol, was often associated with eczematous skin irritation, which may, at least in part, be related to the formulation of miltefosine containing the potentially irritating alkanol propanediol as the vehicle." | 2.75 | Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial. ( Belloni, B; Brockow, K; Eben, R; Hartmann, B; Hartmann, K; Maurer, M; Ruëff, F; Schoepke, N; Siebenhaar, F; Staubach, P; Weber, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartmann, K | 1 |
| Siebenhaar, F | 1 |
| Belloni, B | 1 |
| Brockow, K | 1 |
| Eben, R | 1 |
| Hartmann, B | 1 |
| Ruëff, F | 1 |
| Schoepke, N | 1 |
| Staubach, P | 1 |
| Weber, A | 1 |
| Maurer, M | 1 |
1 trial available for phosphorylcholine and Cutaneous Mastocytosis
| Article | Year |
|---|---|
Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Cell Count; Clobetasol; Double-Blind | 2010 |